交易 Organogenesis Holdings Inc. - ORGO CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
价差 | 0.05 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.025457% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.003235% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Organogenesis Holdings Inc ESG Risk Ratings
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平仓 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Jun 7, 2023 | 4.24 | 0.15 | 3.67% | 4.09 | 4.26 | 4.09 |
Jun 6, 2023 | 4.09 | 0.11 | 2.76% | 3.98 | 4.20 | 3.98 |
Jun 5, 2023 | 4.01 | 0.06 | 1.52% | 3.95 | 4.12 | 3.75 |
Jun 2, 2023 | 3.94 | 0.33 | 9.14% | 3.61 | 3.97 | 3.58 |
Jun 1, 2023 | 3.67 | 0.13 | 3.67% | 3.54 | 3.71 | 3.50 |
May 31, 2023 | 3.62 | -0.16 | -4.23% | 3.78 | 3.81 | 3.56 |
May 30, 2023 | 3.78 | 0.03 | 0.80% | 3.75 | 3.85 | 3.52 |
May 26, 2023 | 3.75 | 0.01 | 0.27% | 3.74 | 3.85 | 3.62 |
May 25, 2023 | 3.78 | -0.15 | -3.82% | 3.93 | 4.00 | 3.73 |
May 24, 2023 | 3.97 | 0.07 | 1.79% | 3.90 | 4.14 | 3.77 |
May 23, 2023 | 3.41 | 0.04 | 1.19% | 3.37 | 3.57 | 3.31 |
May 22, 2023 | 3.39 | 0.23 | 7.28% | 3.16 | 3.52 | 3.16 |
May 19, 2023 | 3.18 | 0.09 | 2.91% | 3.09 | 3.27 | 3.08 |
May 18, 2023 | 3.07 | -0.04 | -1.29% | 3.11 | 3.24 | 2.97 |
May 17, 2023 | 3.14 | 0.13 | 4.32% | 3.01 | 3.22 | 2.94 |
May 16, 2023 | 3.00 | -0.10 | -3.23% | 3.10 | 3.10 | 2.86 |
May 15, 2023 | 3.14 | 0.09 | 2.95% | 3.05 | 3.23 | 2.99 |
May 12, 2023 | 3.08 | 0.24 | 8.45% | 2.84 | 3.17 | 2.84 |
May 11, 2023 | 2.84 | 0.53 | 22.94% | 2.31 | 2.95 | 2.27 |
May 10, 2023 | 2.07 | -0.07 | -3.27% | 2.14 | 2.28 | 2.06 |
Organogenesis Holdings Inc. Events
时间(协调世界时) (UTC) | 国家/地区 | 事件 |
---|---|---|
Tuesday, June 13, 2023 | ||
时间(协调世界时) (UTC) 15:00 | 国家/地区 US
| 事件 Organogenesis Holdings Inc Annual Shareholders Meeting Organogenesis Holdings Inc Annual Shareholders MeetingForecast -Previous - |
Friday, June 23, 2023 | ||
时间(协调世界时) (UTC) 15:00 | 国家/地区 US
| 事件 Organogenesis Holdings Inc Annual Shareholders Meeting Organogenesis Holdings Inc Annual Shareholders MeetingForecast -Previous - |
Monday, August 7, 2023 | ||
时间(协调世界时) (UTC) 20:00 | 国家/地区 US
| 事件 Q2 2023 Organogenesis Holdings Inc Earnings Release Q2 2023 Organogenesis Holdings Inc Earnings ReleaseForecast -Previous - |
Tuesday, November 7, 2023 | ||
时间(协调世界时) (UTC) 10:59 | 国家/地区 US
| 事件 Q3 2023 Organogenesis Holdings Inc Earnings Release Q3 2023 Organogenesis Holdings Inc Earnings ReleaseForecast -Previous - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
总收入 | 450.893 | 468.059 | 338.298 | 260.981 | 193.449 |
收入 | 450.893 | 468.059 | 338.298 | 260.981 | 193.449 |
总营业费用 | 428.589 | 397.024 | 309.352 | 292.697 | 247.1 |
销售/一般/行政费用,总计 | 283.808 | 250.2 | 204.193 | 200.088 | 161.961 |
营业收入 | 22.304 | 71.035 | 28.946 | -31.716 | -53.651 |
税前净收入 | 20.282 | 63.786 | 17.764 | -38.559 | -64.747 |
税后净收入 | 15.532 | 94.902 | 17.234 | -38.709 | -64.831 |
未计算非常项目前的净收益 | 15.532 | 94.902 | 17.234 | -38.709 | -64.831 |
净收入 | 15.532 | 94.902 | 17.234 | -38.709 | -64.831 |
普通股股东可获收益 (不含非经常性项目) | 15.532 | 94.902 | 17.234 | -39.277 | -64.831 |
普通股股东可获收益 (含非經常性項目) | 15.532 | 94.902 | 17.234 | -39.277 | -64.831 |
摊薄净收入 | 15.532 | 94.902 | 17.234 | -39.277 | -64.831 |
摊薄后加权平均股 | 132.383 | 133.663 | 111.361 | 92.8404 | 69.3185 |
扣除特别项目的每股摊薄盈利 | 0.11733 | 0.71001 | 0.15476 | -0.42306 | -0.93526 |
每股正常摊薄盈利 | 0.13045 | 0.74204 | 0.14058 | -0.41002 | -0.91562 |
利息收入(费用),非经营净值 | -2.009 | -7.236 | -11.279 | -6.856 | -11.258 |
Total Adjustments to Net Income | 0 | 0 | -0.568 | ||
收入成本,共计 | 105.019 | 114.199 | 87.319 | 75.948 | 68.808 |
毛利 | 345.874 | 353.86 | 250.979 | 185.033 | 124.641 |
研究与开发 | 39.762 | 30.742 | 20.086 | 14.799 | 10.742 |
利息费用(收入) - 净运营 | 3.494 | ||||
异常费用(收入) | 0 | 1.883 | -2.246 | 1.862 | 2.095 |
其他,净值 | -0.013 | -0.013 | 0.097 | 0.013 | 0.162 |
少数股东权益 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
总收入 | 107.642 | 115.516 | 116.859 | 121.401 | 97.117 |
收入 | 107.642 | 115.516 | 116.859 | 121.401 | 97.117 |
收入成本,共计 | 26.607 | 27.11 | 26.177 | 26.652 | 25.08 |
毛利 | 81.035 | 88.406 | 90.682 | 94.749 | 72.037 |
总营业费用 | 111.643 | 106.798 | 115.08 | 109.466 | 97.245 |
销售/一般/行政费用,总计 | 73.834 | 68.293 | 79.328 | 72.609 | 63.578 |
研究与开发 | 11.202 | 11.395 | 9.575 | 10.205 | 8.587 |
异常费用(收入) | 0 | 0 | |||
营业收入 | -4.001 | 8.718 | 1.779 | 11.935 | -0.128 |
利息收入(费用),非经营净值 | -0.649 | 0.03 | -0.572 | -0.73 | -0.737 |
其他,净值 | 0.023 | 0.006 | 0.005 | -0.021 | -0.003 |
税前净收入 | -4.627 | 8.754 | 1.212 | 11.184 | -0.868 |
税后净收入 | -2.969 | 7.486 | 0.215 | 8.744 | -0.913 |
未计算非常项目前的净收益 | -2.969 | 7.486 | 0.215 | 8.744 | -0.913 |
净收入 | -2.969 | 7.486 | 0.215 | 8.744 | -0.913 |
普通股股东可获收益 (不含非经常性项目) | -2.969 | 7.486 | 0.215 | 8.744 | -0.913 |
普通股股东可获收益 (含非經常性項目) | -2.969 | 7.486 | 0.215 | 8.744 | -0.913 |
摊薄净收入 | -2.969 | 7.486 | 0.215 | 8.744 | -0.913 |
摊薄后加权平均股 | 131.084 | 131.867 | 132.233 | 132.601 | 128.789 |
扣除特别项目的每股摊薄盈利 | -0.02265 | 0.05677 | 0.00163 | 0.06594 | -0.00709 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | -0.01319 | 0.06163 | 0.00463 | 0.06973 | -0.00576 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流动资产总额 | 222.609 | 226.979 | 174.344 | 125.6 | 71.131 |
现金和短期投资 | 102.478 | 113.929 | 84.394 | 60.174 | 21.291 |
Cash | 102.478 | 113.929 | 84.394 | 60.174 | 21.291 |
Prepaid Expenses | 5.086 | 4.969 | 4.935 | 2.953 | 2.328 |
Total Assets | 449.359 | 443.259 | 294.494 | 220.687 | 163.678 |
Other Long Term Assets, Total | 31.534 | 33.531 | 0.688 | 1.011 | 0.817 |
Total Current Liabilities | 75.023 | 82.005 | 68.217 | 59.894 | 66.388 |
Accrued Expenses | 38.155 | 48.374 | 23.973 | 23.45 | |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 2.545 |
Other Current Liabilities, Total | 0 | 1.436 | 0.578 | 5 | 37.177 |
Total Liabilities | 183.69 | 201.224 | 148.41 | 165.104 | 116.637 |
Total Long Term Debt | 66.231 | 70.769 | 64.486 | 97.549 | 49.216 |
Other Liabilities, Total | 42.436 | 48.45 | 15.707 | 7.661 | 1.033 |
Total Equity | 265.669 | 242.035 | 146.084 | 55.583 | 47.041 |
Common Stock | 0.013 | 0.013 | 0.013 | 0.01 | 0.009 |
Additional Paid-In Capital | 310.957 | 302.155 | 299.129 | 226.58 | 177.272 |
Retained Earnings (Accumulated Deficit) | -45.301 | -60.133 | -153.058 | -171.007 | -130.24 |
Total Liabilities & Shareholders’ Equity | 449.359 | 443.259 | 294.494 | 220.687 | 163.678 |
Total Common Shares Outstanding | 130.919 | 128.68 | 127.732 | 104.871 | 91.2614 |
Preferred Stock - Non Redeemable, Net | 0 | ||||
应收账款总额,净额 | 89.45 | 82.46 | 56.804 | 39.359 | 34.077 |
Accounts Receivable - Trade, Net | 89.45 | 82.46 | 56.804 | 39.359 | 34.077 |
Total Inventory | 24.783 | 25.022 | 27.799 | 22.918 | 13.321 |
Other Current Assets, Total | 0.812 | 0.599 | 0.412 | 0.196 | 0.114 |
Property/Plant/Equipment, Total - Net | 145.655 | 128.304 | 60.068 | 47.184 | 39.623 |
Goodwill, Net | 28.772 | 28.772 | 28.772 | 25.539 | 25.539 |
Intangibles, Net | 20.789 | 25.673 | 30.622 | 20.797 | 26.091 |
Note Receivable - Long Term | 0 | 0.556 | 0.477 | ||
Accounts Payable | 32.33 | 29.339 | 23.381 | 28.387 | 19.165 |
Current Port. of LT Debt/Capital Leases | 4.538 | 2.856 | 20.285 | 3.057 | 7.501 |
Long Term Debt | 66.231 | 70.769 | 53.044 | 83.118 | 39.062 |
Capital Lease Obligations | 0 | 11.442 | 14.431 | 10.154 | |
Property/Plant/Equipment, Total - Gross | 208.453 | 186.033 | 129.589 | 112.996 | |
Accumulated Depreciation, Total | -62.798 | -57.729 | -69.521 | -65.812 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 216.822 | 222.609 | 230.526 | 231.543 | 217.851 |
现金和短期投资 | 88.694 | 102.478 | 107.25 | 112.279 | 107.897 |
Cash | 88.694 | 102.478 | 107.25 | 112.279 | 107.897 |
应收账款总额,净额 | 92.021 | 89.45 | 93.115 | 88.824 | 79.477 |
Accounts Receivable - Trade, Net | 92.021 | 89.45 | 93.115 | 88.824 | 79.477 |
Total Inventory | 25.539 | 24.783 | 24.683 | 23.235 | 22.737 |
Prepaid Expenses | 9.847 | 5.086 | 4.707 | 6.54 | 7.135 |
Other Current Assets, Total | 0.721 | 0.812 | 0.771 | 0.665 | 0.605 |
Total Assets | 446.107 | 449.359 | 457.272 | 456.357 | 436.272 |
Property/Plant/Equipment, Total - Net | 149.476 | 145.655 | 142.381 | 139.152 | 131.736 |
Property/Plant/Equipment, Total - Gross | 214.966 | 208.453 | 204.419 | 199.752 | 190.811 |
Accumulated Depreciation, Total | -65.49 | -62.798 | -62.038 | -60.6 | -59.075 |
Goodwill, Net | 28.772 | 28.772 | 28.772 | 28.772 | 28.772 |
Intangibles, Net | 19.56 | 20.789 | 22.01 | 23.231 | 24.452 |
Other Long Term Assets, Total | 31.477 | 31.534 | 33.583 | 33.659 | 33.461 |
Total Current Liabilities | 76.076 | 75.023 | 89.273 | 88.23 | 76.792 |
Accounts Payable | 30.31 | 32.33 | 37.952 | 36.373 | 27.935 |
Accrued Expenses | 40.757 | 38.155 | 46.317 | 48.261 | 44.194 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 5.009 | 4.538 | 5.004 | 3.596 | 3.227 |
Other Current Liabilities, Total | 0 | 0 | 0 | 1.436 | |
Total Liabilities | 182.406 | 183.69 | 200.944 | 201.972 | 193.044 |
Total Long Term Debt | 64.86 | 66.231 | 67.6 | 68.969 | 69.869 |
Long Term Debt | 64.86 | 66.231 | 67.6 | 68.969 | 69.869 |
Capital Lease Obligations | |||||
Other Liabilities, Total | 41.47 | 42.436 | 44.071 | 44.773 | 46.383 |
Total Equity | 263.701 | 265.669 | 256.328 | 254.385 | 243.228 |
Common Stock | 0.013 | 0.013 | 0.013 | 0.013 | 0.013 |
Additional Paid-In Capital | 312.573 | 310.957 | 309.102 | 307.374 | 303.261 |
Retained Earnings (Accumulated Deficit) | -48.885 | -45.301 | -52.787 | -53.002 | -60.046 |
Total Liabilities & Shareholders’ Equity | 446.107 | 449.359 | 457.272 | 456.357 | 436.272 |
Total Common Shares Outstanding | 131.226 | 130.919 | 130.915 | 130.885 | 128.887 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | 15.532 | 94.902 | 17.234 | -40.454 | -64.831 |
经营活动产生的现金 | 24.859 | 61.978 | 5.466 | -33.528 | -60.739 |
营运资金的变化 | -34.082 | -37.71 | -27.757 | -9.667 | -22.401 |
投资活动产生的现金 | -33.898 | -31.22 | -23.498 | -6.234 | -1.856 |
其他投资现金流量项目,总计 | 0 | -5.82 | 0 | 0.001 | |
融资活动产生的现金 | -2.199 | -1.036 | 42.468 | 78.727 | 81.642 |
融资现金流项目 | -1.256 | -1.22 | 55.556 | 46.443 | 80.347 |
股票的发行(报废),净额 | 2.07 | 2.198 | 2.823 | 0.897 | 0.119 |
债务的发行(退还),净额 | -3.013 | -2.014 | -15.911 | 31.387 | 1.176 |
现金净变化 | -11.238 | 29.722 | 24.436 | 38.965 | 19.047 |
非现金物品 | 30.701 | 26.032 | 7.694 | 7.051 | 19.329 |
经营活动产生的现金 | 5.845 | 5.781 | 4.438 | 3.388 | 3.309 |
Amortization | 4.883 | 4.949 | 3.745 | 6.043 | 3.669 |
Deferred Taxes | 1.98 | -31.976 | 0.112 | 0.111 | 0.186 |
资本支出 | -33.898 | -31.22 | -17.678 | -6.234 | -1.857 |
Cash Taxes Paid | 1.201 | 0.607 | 0.061 | 0.049 | |
已付现金利息 | 2.649 | 5.787 | 9.609 | 8.148 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -2.969 | 15.532 | 8.046 | 7.831 | 0.087 |
Cash From Operating Activities | -5.077 | 24.859 | 17.059 | 11.606 | 1.411 |
Cash From Operating Activities | 2.694 | 5.845 | 4.331 | 2.875 | 1.347 |
Amortization | 1.23 | 4.883 | 3.662 | 2.442 | 1.221 |
Non-Cash Items | 5.795 | 30.701 | 23.822 | 12.698 | 5.654 |
Cash Taxes Paid | -0.128 | 1.201 | -0.974 | 0.974 | 0.004 |
Cash Interest Paid | 1.271 | 2.649 | 1.787 | 1.041 | 0.627 |
Changes in Working Capital | -11.827 | -34.082 | -22.802 | -14.24 | -6.898 |
Cash From Investing Activities | -7.562 | -33.898 | -23.242 | -12.84 | -6.672 |
Capital Expenditures | -7.562 | -33.898 | -23.242 | -12.84 | -6.672 |
Cash From Financing Activities | -1.236 | -2.199 | -0.324 | -0.35 | -0.765 |
Financing Cash Flow Items | -0.298 | -1.256 | -1.256 | -1.254 | -0.488 |
Issuance (Retirement) of Stock, Net | 0 | 2.07 | 2.07 | 2.042 | 0.291 |
Issuance (Retirement) of Debt, Net | -0.938 | -3.013 | -1.138 | -1.138 | -0.568 |
Net Change in Cash | -13.875 | -11.238 | -6.507 | -1.584 | -6.026 |
Other Investing Cash Flow Items, Total | |||||
Deferred Taxes | 1.98 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
Ades (Alan A) | Individual Investor | 11.6136 | 15244272 | 0 | 2023-04-10 | LOW |
Nussdorf (Glenn H) | Individual Investor | 11.3999 | 14963663 | 0 | 2023-04-10 | LOW |
Erani (Dennis) | Individual Investor | 7.6517 | 10043701 | -9106 | 2021-12-28 | |
Soleus Capital Management, L.P. | Hedge Fund | 7.5064 | 9853063 | 2490000 | 2023-03-31 | HIGH |
Organo PFG LLC | Corporation | 6.3076 | 8279490 | 0 | 2023-04-10 | LOW |
RED Holdings, L.L.C. | Corporation | 5.6317 | 7392328 | 7392328 | 2021-12-28 | |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.9574 | 3882001 | -6530489 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.8257 | 3709093 | -1105755 | 2023-03-31 | LOW |
Organo Investors, L.L.C. | Corporation | 2.1727 | 2851984 | 0 | 2023-04-10 | LOW |
AQR Capital Management, LLC | Investment Advisor/Hedge Fund | 1.9444 | 2552213 | 361648 | 2023-03-31 | MED |
Citadel Advisors LLC | Hedge Fund | 1.9441 | 2551890 | 1876307 | 2023-03-31 | HIGH |
Two Sigma Investments, LP | Hedge Fund | 1.607 | 2109408 | 468570 | 2023-03-31 | HIGH |
Federated Hermes MDTA LLC | Investment Advisor/Hedge Fund | 1.4436 | 1894916 | -998694 | 2023-03-31 | MED |
Millennium Management LLC | Hedge Fund | 1.207 | 1584274 | -142988 | 2023-03-31 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.1525 | 1512735 | 46040 | 2023-03-31 | LOW |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 1.0732 | 1408713 | 219098 | 2023-03-31 | MED |
Assenagon Asset Management S.A. | Investment Advisor | 1.0401 | 1365197 | -74843 | 2023-03-31 | HIGH |
D. E. Shaw & Co., L.P. | Hedge Fund | 1.0215 | 1340843 | 909003 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.9731 | 1277300 | -1207063 | 2023-03-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.9511 | 1248400 | 75002 | 2023-03-31 | HIGH |
交易计算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Organogenesis Holdings Inc. Company profile
关于 Organogenesis Holdings Inc.
Organogenesis Holdings Inc.是一家再生医学公司,专注于伤口护理和外科及运动医学市场解决方案的开发、生产和商业化。 它的解决方案解决了糖尿病、肥胖症、心血管和外周血管疾病以及吸烟等合并症。 伤口护理产品包括用于治疗静脉性腿部溃疡(VLUs)和糖尿病足溃疡(DFUs)的Apligraf;用于治疗糖尿病足溃疡(DFU)的Dermagraft;作为抗菌屏障的PuraPly AM和PuraPly XT用于各种类型的伤口;以及用于解决各种伤口大小和类型的Affinity和NuShield伤口覆盖物。 其外科和运动医学产品包括用于膝关节骨关节炎治疗的ReNu;用于腰椎骨融合的NuCel;用于定向软组织修复手术的NuShield和Affinity屏障产品;以及用于外科手术中开放伤口管理的PuraPly AM。
Industry: | Biotechnology & Medical Research (NEC) |
85 Dan Rd
CANTON
MASSACHUSETTS 02021-2810
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球535,000万多名交易者的一份子,选择利用Capital.com进行交易吧。